Evidence map›Paper›PMID 30679547›Full record

ArticleScientific reports2019

ES-mediated chimera analysis revealed requirement of DDX6 for NANOS2 localization and function in mouse germ cells.

Ryuki Shimada, Makoto Kiso, Yumiko Saga

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. P-body-like condensates in the germline.Seminars in cell & developmental biology · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ryuki ShimadaDepartment of Genetics, SOKENDAI, Yata 1111, Mishima, Shizuoka, 411-8540, Japan.
Makoto KisoDivision of Mammalian Development, Genetic Strains Research Center, Yata 1111, Mishima, Shizuoka, 411-8540, Japan.
Yumiko SagaDepartment of Genetics, SOKENDAI, Yata 1111, Mishima, Shizuoka, 411-8540, Japan. ysaga@nig.ac.jp.
The Graduate University for Advanced Studies, SOKENDAI · JPNational Institute of Genetics · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In embryonic male germ cells, the RNA-binding protein NANOS2 recruits its target RNAs to processing bodies (P-bodies), where they are repressed. This process is necessary to promote male-type germ cell differentiation. However, it remains unclear whether all NANOS2 functions depend on P-bodies. To address this question, we established ES cell lines containing a germ cell-specific inducible Cre and reporter together with the floxed Ddx6 allele. We deleted the Ddx6 gene by administering tamoxifen to chimeric embryos containing germ cells derived from recombinant ES cells. DDX6-null germ cells exhibited both similar and distinct defects from those observed in NANOS2-null germ cells. These results demonstrate that NANOS2 function is carried out via both P-body-dependent and -independent mechanisms. RNA-seq analyses further supported the phenotypic differences between DDX6-null and NANOS2-null germ cells, and indicated distinct molecular cascades involved in NANOS2-mediated gene regulation.

Indexed as

AnimalsCell LineChimeraCRISPR-Cas SystemsDEAD-box RNA HelicasesEmbryonic Stem CellsFemaleGene DeletionGene Expression Regulation, DevelopmentalGerm CellsMaleMiceProto-Oncogene ProteinsRNA-Binding ProteinsSpermatogenesisTranscriptomeDdx6 protein, mouseDEAD-box RNA HelicasesNanos2 protein, mouseProto-Oncogene ProteinsRNA-Binding Proteins

Identifiers

PMID30679547
PMCPMC6345806
OpenAlexW2913412805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.